Executive Summary As of early 2026, the Bioresorbable Scaffolds (BRS) Market is entering a period of renewed growth, characterized by "second-generation" thin-strut designs. Unlike traditional permanent metallic stents, BRS are designed to provide temporary mechanical support to an artery and then gradually resorb into the body. This "leave-nothing-behind" philosophy aims to restore the natural...